Growth Metrics

OmniAb (OABI) Total Current Liabilities (2021 - 2026)

OmniAb (OABI) reported Total Current Liabilities of $13.6 million for Q1 2026, up 18.93% year-over-year from $11.4 million in Q1 2025, and down 16.54% on a QoQ basis from $16.3 million in Q4 2025.

OmniAb (OABI) has 6 years of Total Current Liabilities data on file, last reported at $13.6 million in Q1 2026.

  • Quarterly Total Current Liabilities rose 18.93% year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (up 18.93% YoY) and the FY2025 annual result came in at $16.3 million, up 7.73% from the prior year.
  • Total Current Liabilities fell to $13.6 million in Q1 2026 per OABI's latest filing, from $16.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $26.0 million in Q4 2022 and bottomed at $5.5 million in Q1 2022.
  • The 5-year median for Total Current Liabilities is $14.4 million (2024), against an average of $15.9 million.
  • The widest annual swing landed in 2022, when Total Current Liabilities surged 10598.67%; it then sank 42.53% in 2024.
  • Tracing OABI's Total Current Liabilities over 5 years: stood at $26.0 million in 2022, then slipped by 11.17% to $23.1 million in 2023, then tumbled by 34.73% to $15.1 million in 2024, then grew by 7.73% to $16.3 million in 2025, then decreased by 16.54% to $13.6 million in 2026.
  • Per Business Quant, the three latest OABI Total Current Liabilities figures stand at $13.6 million (Q1 2026), $16.3 million (Q4 2025), and $13.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.70 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 636.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 66.94 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 13.42 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 3.88 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.11 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.35 Bn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 13.57 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.57 Mn
Dec 31, 2025 16.25 Mn
Sep 30, 2025 13.28 Mn
Jun 30, 2025 12.64 Mn
Mar 31, 2025 11.41 Mn
Dec 31, 2024 15.09 Mn
Sep 30, 2024 14.40 Mn
Jun 30, 2024 14.15 Mn
Mar 31, 2024 17.52 Mn
Dec 31, 2023 23.12 Mn
Sep 30, 2023 25.06 Mn
Jun 30, 2023 24.24 Mn
Mar 31, 2023 21.68 Mn
Dec 31, 2022 26.02 Mn
Sep 30, 2022 10.27 Mn
Jun 30, 2022 6.98 Mn
Mar 31, 2022 5.46 Mn
Dec 31, 2021 20.58 Mn
Sep 30, 2021 95,969.00